{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifjmmfzf22goxvndbha5obgcpeejmp3qylnzl4nmcgejgqg5vn6ua",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mhgnjqg6ag72"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreib5oeik53j7rnwrqmnv6gogmxyitrack5rclgre5l6efws7xotusy"
    },
    "mimeType": "image/jpeg",
    "size": 170798
  },
  "path": "/news/2026-03-fishhook-bonds-cells-longer-prostate.html",
  "publishedAt": "2026-03-19T14:00:02.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, have engineered a new class of supercharged T cells that are stronger, longer-lasting, and more precise at killing prostate cancer cells by fine-tuning how they physically interact with tumor cells.",
  "title": "New 'fishhook' bonds help T cells stick longer to prostate cancer cells"
}